Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
Repigmentation occurred within a few weeks of discontinuing successful depigmentation therapy with monobenzyl ether of hydroquinone, in a patient with extensive vitiligo. Patients undertaking depigmentation therapy should be warned that this may occur. The mechanism is unknown.
Oakley
A M
AM
Department of Dermatology, Waikato Hospital, Hamilton, New Zealand.
D000328:Adult; D005148:Facial Dermatoses / Q000188:drug therapy*; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use*; D008297:Male; D011701:PUVA Therapy; D012008:Recurrence; D012880:Skin Pigmentation / Q000187:drug effects*; D014820:Vitiligo / Q000188:drug therapy*
D006873:Hydroquinones; C006429:monobenzone